These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32556712)

  • 21. Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments.
    Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Transpl Infect Dis; 2016 Aug; 18(4):492-503. PubMed ID: 27218435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intensity adjustment of hematopoietic alogeneic transplantation in acute leukemia].
    Sarmiento M M; Bertín C P; Jara V; Ocqueteau T M; Ramírez V P
    Rev Med Chil; 2016 Sep; 144(9):1112-1118. PubMed ID: 28060971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivorship after allogeneic transplantation-management recommendations for the primary care provider.
    Tichelli A; Rovó A
    Curr Hematol Malig Rep; 2015 Mar; 10(1):35-44. PubMed ID: 25667128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH): A Pilot Randomized Clinical Trial.
    Amonoo HL; Daskalakis E; Wolfe ED; Guo M; Celano CM; Healy BC; Cutler CS; Antin JH; Pirl WF; Park ER; Jim HSL; Lee SJ; LeBlanc TW; El-Jawahri A; Huffman JC
    J Natl Compr Canc Netw; 2024 Jun; 22(2 D):. PubMed ID: 38862012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.
    Bevans MF; Mitchell SA; Barrett AJ; Bishop M; Childs R; Fowler D; Krumlauf M; Prince P; Shelburne N; Wehrlen L
    Health Qual Life Outcomes; 2011 Apr; 9():24. PubMed ID: 21496339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.
    Bergeron A
    Clin Chest Med; 2017 Jun; 38(2):249-262. PubMed ID: 28477637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.
    Bevans MF; Mitchell SA; Barrett JA; Bishop MR; Childs R; Fowler D; Krumlauf M; Prince P; Shelburne N; Wehrlen L; Yang L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):387-95. PubMed ID: 24355521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological states and needs among post-allogeneic hematopoietic stem cell transplantation survivors.
    Yanling S; Pu Y; Duorong X; Zhiyong Z; Ting X; Wenjun X; Xiangzhong Z; Jingwen Z
    Cancer Med; 2023 Aug; 12(15):16637-16648. PubMed ID: 37366300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation.
    Hayakawa J; Miyamura D; Kimura SI; Gomyo A; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Bone Marrow Transplant; 2019 Jul; 54(7):994-1003. PubMed ID: 30337699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
    Alzahrani M; Power M; Abou Mourad Y; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Sanford D; Song K; Sutherland H; Toze C; Nevill T; Narayanan S
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1209-1215. PubMed ID: 29474870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation.
    Jim HS; Sutton SK; Jacobsen PB; Martin PJ; Flowers ME; Lee SJ
    Cancer; 2016 Apr; 122(8):1290-7. PubMed ID: 26814442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation.
    Newcomb R; Johnson PC; Cronin K; Choe JJ; Holmbeck K; Nabily A; Lark P; Rabideau DJ; DeFilipp Z; Chen YB; El-Jawahri A
    Transplant Cell Ther; 2023 Jun; 29(6):387.e1-387.e7. PubMed ID: 36958693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.
    Gruber I; Koelbl O; Herr W; Holler E; Edinger M; Wolff D
    Radiat Oncol; 2022 Nov; 17(1):195. PubMed ID: 36447269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.
    Solh MM; Bashey A; Solomon SR; Morris LE; Zhang X; Brown S; Holland HK
    Bone Marrow Transplant; 2018 May; 53(5):576-583. PubMed ID: 29335633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan.
    Hayakawa A; Sato I; Kamibeppu K; Ishida Y; Inoue M; Sato A; Shiohara M; Yabe H; Koike K; Adachi S; Atsuta Y; Yamashita T; Kanda Y; Okamoto S
    Int J Hematol; 2022 Jan; 115(1):123-128. PubMed ID: 34601694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic Transplant.
    Solomon SR; Sizemore C; Zhang X; Ridgeway M; Solh M; Morris LE; Holland HK; Bashey A
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1208-1214. PubMed ID: 28390985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.
    Morken CM; Tevaarwerk AJ; Swiecichowski AK; Haine JE; Williams ZT; Norslien K; Arroyo N; Zhang X; Campbell B; Mendonca EA; Juckett MB; Sesto ME
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1240-1246. PubMed ID: 30763727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.